Shareholders with a substantial shareholding – at least 3% – or short position of the issued share capital of Redcare Pharmacy must notify the Netherlands Authority for Financial Markets (AFM). The AFM must also be notified if, as a result of acquiring or disposing of an interest in Redcare Pharmacy’s capital or voting rights, the percentage of outstanding capital interest or voting rights held reaches, exceeds or falls below any of the following thresholds:
| 3% | 25% | 75% |
| 5% | 30% | 95% |
| 10% | 40% |
| 15% | 50% |
| 20% | 60% |
Notification is further required if, as a result of a change in the total outstanding capital or voting rights of Redcare Pharmacy, the percentage of outstanding capital interest or voting rights held reaches, exceeds or falls below any of the above thresholds.
The following table lists the shareholders on record that hold an interest of 3% or more in the share capital of the Company according to the AFM (as at 22 October 2024):
| Institutional | Voting rights | Shareholding | Reported date |
| DWS Investment GmbH | 5.6% | 5.1% | 28/08/2024 |
| Smallcap World Fund Inc. | 5.2% | 5.2% | 04/09/2024 |
| UBS Group AG | 3.4% | 3.4% | 11/10/2024 |
| T.Rowe Price Group Inc. | 3.0% | 3.0% | 07/10/2024 |
| BlackRock Inc. | 3.0% | 2.7% | 04/04/2024 |
| Private | Voting rights | Shareholding | Reported date |
| C. Laubmann | 4.2% | 4.2% | 19/05/2023 |
| H.R. Hess | 3.2% | 3.2% | 19/05/2023 |
The percentages shown include both direct and indirect capital interests and voting rights and both real and potential capital interest and voting rights. Further details can be found at www.afm.nl
